4.7 Article

Impact of the Structure of Biocompatible Aliphatic Polycarbonates on siRNA Transfection Ability

Journal

BIOMACROMOLECULES
Volume 16, Issue 3, Pages 769-779

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/bm501676p

Keywords

-

Funding

  1. Belgium National Fund for Scientific Research
  2. TELEVIE
  3. Centre Anti-Cancereux
  4. Fonds Leon Fredericq pres de l'Universite de Liege
  5. Belgian Federal Government Office Policy of Science (SSTC)
  6. European Commission
  7. Wallonia Region (FEDER Program)
  8. OPTI2MAT program of excellence

Ask authors/readers for more resources

RNAi therapeutics are promising therapeutic tools that have sparked the interest of many researchers. In an effort to provide a safe alternative to PEI, we have designed a series of new guanidinium- and morpholino-functionalized biocompatible and biodegradable polycarbonate vectors. The impact of different functions (morpholino-, guanidinium-, hydrophobic groups) of the architecture (linear homopolymer to dumbbell-shape) and of the molecular weight of these copolymers on their capacity to form polyplexes and to decrease the expression of two epigenetic regulators of gene expression, HDAC7 and HDAC5, was evaluated. The use of one of these polymers combining morpholine and guanidine functions at the ratio >1 and hydrophobic trimethylene carbonate groups showed a significant decrease of mRNA and protein level in HeLa cells, similar to PEI. These results highlight the potential of polycarbonate vectors for future in vivo application as an anticancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA

Antoine Bernard, Christophe Hibos, Corentin Richard, Etienne Viltard, Sandy Chevrier, Sophie Lemoine, Josephine Melin, Etienne Humblin, Romain Mary, Theo Accogli, Fanny Chalmin, Melanie Bruchard, Paul Peixoto, Eric Hervouet, Lionel Apetoh, Francois Ghiringhelli, Frederique Vegran, Romain Boidot

Summary: The tumor microenvironment (TME) influences immune cell activity by increasing alternative splicing events, leading to the expression of IRF1 Delta 7 in Th1 cells and subsequently decreasing IFN gamma secretion. Inhibiting the expression of IRF1 Delta 7 could enhance Th1 antitumor responses.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Chemistry, Analytical

Development of a prototype device for near real-time surface-enhanced Raman scattering monitoring of biological samples

Elodie Dumont, Charlotte De Bleye, Gilles Rademaker, Laureen Coic, Julie Horne, Pierre-Yves Sacre, Olivier Peulen, Philippe Hubert, Eric Ziemons

Summary: A new methodology combining solid SERS substrates, a protein filtering device, and a handheld Raman analyzer enables near real-time, non-invasive, and non-destructive SERS monitoring of biological samples. This method has shown promising versatility and the capability to reduce cellular stress and contamination hazards.

TALANTA (2021)

Article Oncology

SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer

Rafael S. Martinez, Mark J. Salji, Linda Rushworth, Chara Ntala, Giovanny Rodriguez Blanco, Ann Hedley, William Clark, Paul Peixoto, Eric Hervouet, Elodie Renaude, Sonia H. Y. Kung, Laura C. A. Galbraith, Colin Nixon, Sergio Lilla, Gillian M. Mackay, Ladan Fazli, Luke Gaughan, David Sumpton, Martin E. Gleave, Sara Zanivan, Arnaud Blomme, Hing Y. Leung

Summary: This study identified SLFN5 as a novel regulator of the LAT1 amino acid transporter in castration-resistant prostate cancer (CRPC), contributing to mTORC1 activity. High expression of SLFN5 in CRPC tumors was correlated with poor patient outcome, indicating its clinical relevance as a potential target for CRPC treatment.

CANCER RESEARCH (2021)

Review Immunology

Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy

Elodie Renaude, Marie Kroemer, Christophe Borg, Paul Peixoto, Eric Hervouet, Romain Loyon, Olivier Adotevi

Summary: The review discusses the role of CD4(+) Th cells in anticancer immunity and emphasizes the importance of epigenetics. Research describes how epigenetic factors regulate the differentiation and recruitment of CD4(+) T cells. Furthermore, the potential of using epigenetic drugs to enhance anticancer immunotherapy is explored.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers

Camille Lachat, Paul Peixoto, Eric Hervouet

Summary: Epithelial to mesenchymal transition (EMT) is a process that allows cells to acquire a mesenchymal phenotype, first studied in embryonic development. It has now become an important field in cancer research, as it has been shown to play various roles in cancer progression.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer

Seng Chuan Tang, Quentin Lion, Olivier Peulen, Philippe Chariot, Arnaud Lavergne, Alice Mayer, Paula Allepuz Fuster, Pierre Close, Sebastian Klein, Alexandra Florin, Reinhard Buettner, Ivan Nemazanyy, Kateryna Shostak, Alain Chariot

Summary: COP1 acts as an oncogenic E3 ligase by promoting ERα signaling but also acts as a tumor suppressor candidate by preventing EMT, reflecting a dual role of COP1 in breast cancer that has sparked widespread interest in the academic community.

ONCOGENE (2022)

Article Multidisciplinary Sciences

DHX15-independent roles for TFIP11 in U6 snRNA modification, U4/U6.U5 tri-snRNP assembly and pre-mRNA splicing fidelity

Amandine Duchemin, Tina O'Grady, Sarah Hanache, Agnes Mereau, Marc Thiry, Ludivine Wacheul, Catherine Michaux, Eric Perpete, Eric Hervouet, Paul Peixoto, Felix G. M. Ernst, Yann Audic, Franck Dequiedt, Denis L. J. Lafontaine, Denis Mottet

Summary: TFIP11, a human homolog of the yeast spliceosome disassembly factor Ntr1, is essential for U6 snRNA 2'-O-methylation and U4/U6.U5 tri-snRNP assembly, independently of its known partner DHX15. This reveals a previously unrecognized function of TFIP11 in spliceosome assembly regulation in human cells.

NATURE COMMUNICATIONS (2021)

Article Polymer Science

Synthesis of Polyacids by Copolymerization of L-Lactide with MTC-COOH Using Zn[(acac)(L)H2O] Complex as an Initiator

Joanna Jaworska, Michal Sobota, Malgorzata Pastusiak, Michal Kawalec, Henryk Janeczek, Piotr Rychter, Kamila Lewicka, Piotr Dobrzynski

Summary: This work presents the results of research on the preparation of bioresorbable functional polyestercarbonates containing side carboxyl groups. The simplified one-step method allows obtaining copolymers with all carbonate units containing carboxyl groups, avoiding the issue of heavy metals residue from the traditional method.

POLYMERS (2022)

Review Chemistry, Analytical

Diatom biosilica: Source, physical-chemical characterization, modification, and application

Hussam A. AL Saoud, Myroslav Sprynskyy, Reza Pashaei, Michal Kawalec, Pawel Pomastowski, Boguslaw Buszewski

Summary: Diatomaceous biosilica is a unique and renewable material with various applications in different industries due to its chemical inertness, biocompatibility, and high stability.

JOURNAL OF SEPARATION SCIENCE (2022)

Article Biochemistry & Molecular Biology

Elp3-mediated codon-dependent translation promotes mTORC2 activation and regulates macrophage polarization

Dawei Chen, Ivan Nemazanyy, Olivier Peulen, Kateryna Shostak, Xinyi Xu, Seng Chuan Tang, Caroline Wathieu, Silvia Turchetto, Sylvia Tielens, Laurent Nguyen, Pierre Close, Christophe Desmet, Sebastian Klein, Alexandra Florin, Reinhard Buttner, Georgios Petrellis, Benjamin Dewals, Alain Chariot

Summary: This study reveals the involvement of translational reprogramming in macrophage polarization, with a focus on the role of the Elongator complex subunit Elp3. Elp3 expression is regulated by different activating signals, with M1 signals downregulating its expression and M2 signals upregulating it. The metabolic reprogramming associated with M2 macrophage polarization is dependent on Elp3 and the translation of specific genes. Additionally, Elp3 plays a role in mTORC2 activation and the initiation of Wnt-driven tumor in the intestine by maintaining a pool of M2-like tumor-associated macrophages.

EMBO JOURNAL (2022)

Article Oncology

Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination

Gilles Rademaker, Brunella Costanza, Sebastien Pyr Dit Ruys, Raphael Peiffer, Ferman Agirman, Naima Maloujahmoum, Didier Vertommen, Andrei Turtoi, Akeila Bellahcene, Vincent Castronovo, Olivier Peulen

Summary: Paladin is identified as a potential biomarker for colon cancer liver metastases, and its depletion inhibits colon cancer cell migration and metastasis.

ONCOGENESIS (2022)

Article Biochemistry & Molecular Biology

Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells

Gilles Rademaker, Yasmine Boumahd, Raphael Peiffer, Sandy Anania, Tom Wissocq, Maude Liegeois, Geraldine Luis, Nor Eddine Sounni, Ferman Agirman, Naima Maloujahmoum, Pascal De Tullio, Marc Thiry, Akeila Bellahcene, Vincent Castronovo, Olivier Peulen

Summary: The pharmacological compound WJ460, targeting myoferlin, triggers mitophagy and ROS accumulation, leading to lipid peroxidation and apoptosis-independent cell death. Inhibitors of mitophagy and iron chelators can suppress myoferlin-induced ROS production and restore cell growth. Additionally, a synergic effect exists between ferroptosis inducers and WJ460.

REDOX BIOLOGY (2022)

Article Engineering, Biomedical

Diatomaceous earth as a drug-loaded carrier in a glass-ionomer cement

Magdalena Lepicka, Magdalena Rodziewicz, Michal Kawalec, Klaudia Nowicka, Yurii Tsybrii, Krzysztof Jan Kurzydlowski

Summary: The effect of introducing diatomaceous earth as a filler in a glass-ionomer cement matrix was investigated. The results showed that diatomaceous earth particles are uniformly distributed in the matrix and can enhance surface microhardness and roughness, but have no effect on wear performance or compressive strength.

JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2022)

Review Oncology

Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer

Raphael Peiffer, Yasmine Boumahd, Charlotte Gullo, Rebekah Crake, Elisabeth Letellier, Akeila Bellahcene, Olivier Peulen

Summary: Cancer-associated fibroblasts (CAFs) play a critical role in pancreatic cancer by influencing cancer cell metabolism through various mechanisms. CAF heterogeneity is characteristic of the pancreatic tumor microenvironment. Environmental changes in pH, oxygenation, and nutrient availability are heavily driven by stromal CAFs. The bidirectional crosstalk between CAFs and cancer cells promotes tumor aggressiveness and adaptation to external stress. This review summarizes the diversity of CAF subtypes, the metabolic crosstalk between CAFs and tumor cells, and the role of CAF-driven signaling, desmoplasia, and acidosis in cancer cell metabolism, highlighting potential therapeutic strategies.

CANCERS (2023)

Article Cell Biology

Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response

Rebekah Crake, Imene Gasmi, Jordan Dehaye, Fanny Lardinois, Raphael Peiffer, Naima Maloujahmoum, Ferman Agirman, Benjamin Koopmansch, Nicky D'Haene, Oier Azurmendi Senar, Tatjana Arsenijevic, Frederic Lambert, Olivier Peulen, Jean-Luc Van Laethem, Akeila Bellahcene

Summary: PDAC patients with elevated levels of oncometabolite methylglyoxal (MG) and glyoxalase 1 (GLO1) present with poor prognosis. PDAC cells resistant to gemcitabine show increased glycolysis and MG stress compared to parental cells. Induction of MG stress and heat shock response (HSR) activation by gemcitabine can be efficiently reversed with potent MG scavengers, improving the outcomes of gemcitabine therapy in PDAC.

CELLS (2023)

No Data Available